Benralizumab for adolescent patients with severe, eosinophilic asthma: Safety and efficacy after three years of treatment
The Journal of Allergy and Clinical Immunology | Feb 20, 2021
Most read this week
The Journal of Allergy and Clinical Immunology | Feb 20, 2021